EVO – Evotec SE

EVO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.12

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

-0.01

EPS This/Next Y

0.31

Price

2.42

Target Price

3.8

Analyst Recom

2.09

Performance Q

-22.68

Upside

-554.5%

Beta

1.93

Ticker: EVO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	EVO	3.42	N/A	N/A	0
2026-03-02	EVO	3.3	N/A	N/A	0
2026-03-03	EVO	3.08	N/A	N/A	0
2026-03-04	EVO	3.28	N/A	N/A	0
2026-03-05	EVO	3.12	N/A	N/A	0
2026-03-06	EVO	3.08	N/A	N/A	0
2026-03-09	EVO	3.03	N/A	N/A	0
2026-03-10	EVO	2.66	N/A	N/A	0
2026-03-11	EVO	2.5	N/A	N/A	0
2026-03-12	EVO	2.43	N/A	N/A	0
2026-03-13	EVO	2.41	N/A	N/A	0
2026-03-17	EVO	2.47	N/A	N/A	0
2026-03-18	EVO	2.45	N/A	N/A	0
2026-03-19	EVO	2.45	N/A	N/A	0
2026-03-20	EVO	2.41	N/A	N/A	0
2026-03-23	EVO	2.38	N/A	N/A	0
2026-03-24	EVO	2.36	N/A	N/A	0
2026-03-25	EVO	2.52	N/A	N/A	0
2026-03-26	EVO	2.47	N/A	N/A	0
2026-03-27	EVO	2.42	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	EVO	3.41	-	88.8	-0.66
2026-03-02	EVO	3.29	-	108.8	-0.66
2026-03-03	EVO	3.07	-	109.9	-0.66
2026-03-04	EVO	3.28	-	105.4	-0.66
2026-03-05	EVO	3.12	-	109.2	-0.66
2026-03-06	EVO	3.08	-	108.1	-0.66
2026-03-09	EVO	3.03	-	110.9	-0.66
2026-03-10	EVO	2.67	-	114.3	-0.66
2026-03-11	EVO	2.50	-	113.0	-0.66
2026-03-12	EVO	2.44	-	111.3	-0.66
2026-03-13	EVO	2.32	-	112.4	-0.66
2026-03-17	EVO	2.46	-	106.2	-0.66
2026-03-18	EVO	2.45	-	106.5	-0.66
2026-03-19	EVO	2.46	-	106.3	-0.66
2026-03-20	EVO	2.43	-	106.8	-0.66
2026-03-23	EVO	2.38	-	107.5	-0.66
2026-03-24	EVO	2.35	-	108.1	-0.66
2026-03-25	EVO	2.52	-	105.4	-0.66
2026-03-26	EVO	2.46	-	106.2	-0.66
2026-03-27	EVO	2.42	-	107.0	-0.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	EVO	0.00	-1.44	0.08
2026-03-02	EVO	0.00	-1.88	0.08
2026-03-03	EVO	0.00	-1.88	0.08
2026-03-04	EVO	0.00	-1.88	0.08
2026-03-05	EVO	0.00	-1.88	0.08
2026-03-06	EVO	0.00	-1.88	0.08
2026-03-09	EVO	0.00	-1.83	0.08
2026-03-10	EVO	0.00	-1.83	0.08
2026-03-11	EVO	0.00	-1.83	0.10
2026-03-12	EVO	0.00	-1.83	0.10
2026-03-13	EVO	0.00	-1.83	0.10
2026-03-17	EVO	0.00	-1.86	0.10
2026-03-18	EVO	0.00	-1.86	0.10
2026-03-19	EVO	0.00	-1.86	0.10
2026-03-20	EVO	0.00	-1.86	0.10
2026-03-23	EVO	0.00	-2.11	0.10
2026-03-24	EVO	0.00	-2.11	0.10
2026-03-25	EVO	0.00	-2.11	0.12
2026-03-26	EVO	0.00	-2.11	0.12
2026-03-27	EVO	0.00	-2.11	0.12
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.07

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-2.11

Beta

1.93

Average Sales Estimate Current Quarter

239

Average Sales Estimate Next Quarter

215

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.9

Max Drawdown 5-Year %

-91.3

Target Price

3.8

P/E

Forward P/E

PEG

P/S

1.03

P/B

0.91

P/Free Cash Flow

EPS

-0.5

Average EPS Est. Cur. Y

-0.66

EPS Next Y. (Est.)

-0.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-21.2

Relative Volume

0.35

Return on Equity vs Sector %

-47.2

Return on Equity vs Industry %

-27

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.13

EBIT Estimation

107

◆ EVO Healthcare

$2.42

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

18/20

Pullback

15/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

0/10

RSI

34.5

Range 1M

11%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

13/30

Estimates

0/20

Inst/Vol

0/15

Options

0/10

EPS Yr

59%

EPS NY

10%

52W%

4.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +57% upside

Quality

3/30

Valuation

12/30

Growth

8/25

Stability

5/10

LT Trend

4/5

Upside

+57%

Quality

Evotec SE

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 4788

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; central nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. The company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

EVO

Latest News

—

Caricamento notizie per EVO…

stock quote shares EVO – Evotec SE Stock Price stock today

news today EVO – Evotec SE stock forecast ,stock prediction 2023 2024 2025

marketwatch EVO – Evotec SE yahoo finance google finance

stock history EVO – Evotec SE invest stock market

stock prices EVO premarket after hours

ticker EVO fair value insiders trading

VJET – Voxeljet AG ADR

VJET — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.11

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.19

Price

Target Price

2.67

Analyst Recom

Performance Q

-45.29

Upside

N/A

Beta

1.07

Ticker: VJET

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	VJET	0.6401	N/A	N/A	0
2026-03-03	VJET	0.6401	N/A	N/A	0
2026-03-04	VJET	0.6401	N/A	N/A	0
2026-03-06	VJET	0.6401	N/A	N/A	0
2026-03-09	VJET	0.6401	N/A	N/A	0
2026-03-10	VJET	0.6401	N/A	N/A	0
2026-03-11	VJET	0.6401	N/A	N/A	0
2026-03-12	VJET	0.6401	N/A	N/A	0
2026-03-13	VJET	0.6401	N/A	N/A	0
2026-03-17	VJET	0.6401	N/A	N/A	0
2026-03-18	VJET	0.6401	N/A	N/A	0
2026-03-20	VJET	0.6401	N/A	N/A	0
2026-03-25	VJET	0.6401	N/A	N/A	0
2026-03-26	VJET	0.6401	N/A	N/A	0
2026-03-27	VJET	0.6401	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.49

Avg. EPS Est. Next Quarter

-0.3

Insider Transactions

Institutional Transactions

80.2

Beta

1.07

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.5

Max Drawdown 5-Year %

-98.7

Target Price

2.67

P/E

Forward P/E

PEG

P/S

0.18

P/B

0.38

P/Free Cash Flow

EPS

-1.2

Average EPS Est. Cur. Y

-1.62

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-34.59

Relative Volume

Return on Equity vs Sector %

-119.2

Return on Equity vs Industry %

-106.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

No data found for VJET

VJET

Latest News

—

Caricamento notizie per VJET…

stock quote shares VJET – Voxeljet AG ADR Stock Price stock today

news today VJET – Voxeljet AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch VJET – Voxeljet AG ADR yahoo finance google finance

stock history VJET – Voxeljet AG ADR invest stock market

stock prices VJET premarket after hours

ticker VJET fair value insiders trading

IMTX – Immatics N.V

IMTX — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

4.71

Margin Of Safety %

Put/Call OI Ratio

0.67

EPS Next Q Diff

-0.12

EPS Last/This Y

0.16

EPS This/Next Y

-0.02

Price

9.37

Target Price

18.44

Analyst Recom

Performance Q

-9.64

Upside

-352.5%

Beta

1.33

Ticker: IMTX

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	IMTX	10.35	1.34	3.33	795
2026-03-03	IMTX	9.81	1.38	26.83	819
2026-03-04	IMTX	10.02	1.82	10.00	986
2026-03-06	IMTX	9.82	1.86	13.00	1008
2026-03-09	IMTX	9.98	1.88	999.99	1018
2026-03-10	IMTX	10.46	1.91	16.36	1028
2026-03-11	IMTX	10.02	2.26	40.00	1175
2026-03-12	IMTX	9.4	2.26	40.00	1175
2026-03-13	IMTX	9.41	2.26	40.00	1175
2026-03-17	IMTX	9.85	2.78	0.00	1381
2026-03-18	IMTX	9.72	2.71	999.99	1391
2026-03-20	IMTX	9.46	2.69	33.33	1407
2026-03-25	IMTX	9.72	0.82	0.10	667
2026-03-26	IMTX	9.76	0.82	0.10	667
2026-03-27	IMTX	9.38	0.67	11.00	776
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	IMTX	10.34	-205.1	-	-1.97
2026-03-02	IMTX	9.98	-205.1	-	-1.97
2026-03-03	IMTX	9.84	-205.1	-	-1.97
2026-03-04	IMTX	10.17	-205.1	-	-1.97
2026-03-05	IMTX	10.15	-205.1	-	-1.97
2026-03-06	IMTX	9.83	-205.1	-	-1.97
2026-03-09	IMTX	9.98	-21.9	-	-1.97
2026-03-10	IMTX	10.47	-21.9	-	-1.76
2026-03-11	IMTX	10.02	-21.9	-	-1.76
2026-03-12	IMTX	9.39	-21.9	-	-1.76
2026-03-13	IMTX	9.24	-19.3	-	-1.76
2026-03-17	IMTX	9.85	-19.3	-	-1.68
2026-03-18	IMTX	9.72	-19.3	-	-1.68
2026-03-19	IMTX	9.70	-19.3	-	-1.74
2026-03-20	IMTX	9.47	-18.7	-	-1.74
2026-03-23	IMTX	9.52	-18.7	-	-1.74
2026-03-24	IMTX	9.19	-18.7	-	-1.74
2026-03-25	IMTX	9.73	-18.7	-	-1.74
2026-03-26	IMTX	9.77	-18.7	-	-1.74
2026-03-27	IMTX	9.37	-18.7	-	-1.74
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	IMTX	0.00	-10.45	5.07
2026-03-02	IMTX	0.00	8.89	5.07
2026-03-03	IMTX	0.00	8.89	5.07
2026-03-04	IMTX	0.00	8.89	5.07
2026-03-05	IMTX	0.00	8.89	5.07
2026-03-06	IMTX	0.00	8.89	5.07
2026-03-09	IMTX	0.00	7.99	5.07
2026-03-10	IMTX	0.00	7.99	5.07
2026-03-11	IMTX	0.00	7.99	4.79
2026-03-12	IMTX	0.00	7.99	4.79
2026-03-13	IMTX	0.00	7.99	4.79
2026-03-18	IMTX	0.00	7.99	4.79
2026-03-19	IMTX	0.00	7.99	4.79
2026-03-20	IMTX	0.00	7.99	4.79
2026-03-23	IMTX	0.00	7.99	4.79
2026-03-24	IMTX	0.00	7.99	4.79
2026-03-25	IMTX	0.00	7.99	4.71
2026-03-26	IMTX	0.00	7.99	4.71
2026-03-27	IMTX	0.00	7.99	4.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.34

Avg. EPS Est. Current Quarter

-0.44

Avg. EPS Est. Next Quarter

-0.46

Insider Transactions

Institutional Transactions

7.99

Beta

1.33

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

42.5

Max Drawdown 5-Year %

-77.4

Target Price

18.44

P/E

Forward P/E

PEG

P/S

23.27

P/B

2.21

P/Free Cash Flow

EPS

-1.82

Average EPS Est. Cur. Y

-1.74

EPS Next Y. (Est.)

-1.77

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-411.76

Relative Volume

0.66

Return on Equity vs Sector %

-67.9

Return on Equity vs Industry %

-51.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.09

EBIT Estimation

◆ IMTX Healthcare

$9.37

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

9/25

Volume

9/15

Valuation

9/20

TP/AR

4/10

Options

3/10

RSI

44.6

Range 1M

54.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

9/30

Estimates

2/20

Inst/Vol

6/15

Options

4/10

EPS Yr

4.1%

EPS NY

0.8%

52W%

73%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +96.8% upside

Quality

2/30

Valuation

14/30

Growth

6/25

Stability

8/10

LT Trend

3/5

Upside

+96.8%

Quality

Immatics N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 589

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes Anzu-cel (IMA203), a one-time infusion PRAME cell therapy, which is in Phase 2 trial; IMA203CD8, a cell therapy product that is in Phase 1 clinical trial; IMA204 that targets tumor stroma, which is in Phase 1 clinical trial; and Anzu-cel in combination with Moderna's PRAME cell therapy enhancer (mRNA-4203), which is in Phase 1 clinical trial. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

IMTX

Latest News

—

Caricamento notizie per IMTX…

stock quote shares IMTX – Immatics N.V Stock Price stock today

news today IMTX – Immatics N.V stock forecast ,stock prediction 2023 2024 2025

marketwatch IMTX – Immatics N.V yahoo finance google finance

stock history IMTX – Immatics N.V invest stock market

stock prices IMTX premarket after hours

ticker IMTX fair value insiders trading

FMS – Fresenius Medical Care AG ADR

FMS — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.33

Margin Of Safety %

Put/Call OI Ratio

1.12

EPS Next Q Diff

-0.31

EPS Last/This Y

0.57

EPS This/Next Y

0.93

Price

22.07

Target Price

25.59

Analyst Recom

2.95

Performance Q

-8.27

Upside

91.5%

Beta

0.87

Ticker: FMS

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	FMS	23.47	0.76	999.99	3977
2026-03-03	FMS	23.36	0.76	0.50	3978
2026-03-04	FMS	23.03	0.76	3.00	3981
2026-03-06	FMS	22.97	0.76	999.99	3986
2026-03-09	FMS	23.42	0.76	999.99	3986
2026-03-10	FMS	22.97	0.76	999.99	3986
2026-03-11	FMS	22.74	0.83	0.00	4130
2026-03-12	FMS	22.76	0.83	0.00	4130
2026-03-13	FMS	22.75	0.83	0.00	4130
2026-03-17	FMS	23.16	0.85	0.00	4079
2026-03-18	FMS	22.4	0.85	0.00	4079
2026-03-20	FMS	21.65	0.84	0.03	4110
2026-03-25	FMS	22.26	1.12	999.99	3213
2026-03-26	FMS	22.37	1.12	0.00	3214
2026-03-27	FMS	22.07	1.12	999.99	3217
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	FMS	23.47	22.4	587.6	2.62
2026-03-02	FMS	23.47	24.3	653.0	2.56
2026-03-03	FMS	23.37	24.3	648.9	2.56
2026-03-04	FMS	23.02	24.3	635.4	2.56
2026-03-05	FMS	23.05	24.3	667.5	2.56
2026-03-06	FMS	22.96	24.3	659.9	2.56
2026-03-09	FMS	23.43	18.9	675.1	2.56
2026-03-10	FMS	22.98	18.9	619.6	2.56
2026-03-11	FMS	22.73	18.9	609.8	2.56
2026-03-12	FMS	22.74	18.9	624.3	2.55
2026-03-13	FMS	22.78	18.9	-85.5	2.55
2026-03-17	FMS	23.15	18.9	-77.7	2.55
2026-03-18	FMS	22.40	18.9	-134.1	2.55
2026-03-19	FMS	22.12	18.9	-114.9	2.55
2026-03-20	FMS	21.65	18.9	-120.4	2.55
2026-03-23	FMS	21.89	18.9	-95.2	2.55
2026-03-24	FMS	22.03	18.9	-102.4	2.55
2026-03-25	FMS	22.28	18.9	-102.8	2.55
2026-03-26	FMS	22.36	18.9	-111.6	2.55
2026-03-27	FMS	22.07	18.9	-130.9	2.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	FMS	0.00	0.13	0.32
2026-03-02	FMS	0.00	-0.31	0.33
2026-03-03	FMS	0.00	-0.31	0.33
2026-03-04	FMS	0.00	-0.31	0.33
2026-03-05	FMS	0.00	-0.31	0.33
2026-03-06	FMS	0.00	-0.31	0.33
2026-03-09	FMS	0.00	-0.39	0.33
2026-03-10	FMS	0.00	-0.39	0.33
2026-03-11	FMS	0.00	-0.39	0.37
2026-03-12	FMS	0.00	-0.39	0.37
2026-03-13	FMS	0.00	-0.39	0.37
2026-03-17	FMS	0.00	-0.37	0.37
2026-03-18	FMS	0.00	-0.37	0.37
2026-03-19	FMS	0.00	-0.37	0.37
2026-03-20	FMS	0.00	-0.37	0.37
2026-03-23	FMS	0.00	-0.35	0.37
2026-03-24	FMS	0.00	-0.35	0.37
2026-03-25	FMS	0.00	-0.35	0.33
2026-03-26	FMS	0.00	-0.35	0.33
2026-03-27	FMS	0.00	-0.35	0.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.83

Avg. EPS Est. Current Quarter

0.5

Avg. EPS Est. Next Quarter

0.52

Insider Transactions

Institutional Transactions

-0.35

Beta

0.87

Average Sales Estimate Current Quarter

4726

Average Sales Estimate Next Quarter

4789

Fair Value

24.17

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-68.8

Target Price

25.59

P/E

11.48

Forward P/E

8.53

PEG

1.69

P/S

0.56

P/B

0.79

P/Free Cash Flow

6.16

EPS

1.92

Average EPS Est. Cur. Y

2.55

EPS Next Y. (Est.)

3.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.03

Relative Volume

0.45

Return on Equity vs Sector %

-20

Return on Equity vs Industry %

-125.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.37

EBIT Estimation

-130.9

◆ FMS Healthcare

$22.06

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

11/15

Valuation

16/20

TP/AR

0/10

Options

2/10

RSI

40.9

Range 1M

40.5%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

11/30

Estimates

4/20

Inst/Vol

0/15

Options

3/10

EPS Yr

-5.5%

EPS NY

8.7%

52W%

15%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +129.6% upside

Quality

6/30

Valuation

20/30

Growth

9/25

Stability

3/10

LT Trend

1/5

Upside

+129.6%

Quality

MoS

10%

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 109698

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FMS

Latest News

—

Caricamento notizie per FMS…

stock quote shares FMS – Fresenius Medical Care AG ADR Stock Price stock today

news today FMS – Fresenius Medical Care AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG ADR yahoo finance google finance

stock history FMS – Fresenius Medical Care AG ADR invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

FMS – Fresenius Medical Care AG & Co. KGaA

FMS — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.33

Margin Of Safety %

Put/Call OI Ratio

1.12

EPS Next Q Diff

-0.31

EPS Last/This Y

0.57

EPS This/Next Y

0.93

Price

22.07

Target Price

25.59

Analyst Recom

2.95

Performance Q

-8.27

Upside

91.5%

Beta

0.87

Ticker: FMS

15 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	FMS	23.47	0.76	999.99	3977
2026-03-03	FMS	23.36	0.76	0.50	3978
2026-03-04	FMS	23.03	0.76	3.00	3981
2026-03-06	FMS	22.97	0.76	999.99	3986
2026-03-09	FMS	23.42	0.76	999.99	3986
2026-03-10	FMS	22.97	0.76	999.99	3986
2026-03-11	FMS	22.74	0.83	0.00	4130
2026-03-12	FMS	22.76	0.83	0.00	4130
2026-03-13	FMS	22.75	0.83	0.00	4130
2026-03-17	FMS	23.16	0.85	0.00	4079
2026-03-18	FMS	22.4	0.85	0.00	4079
2026-03-20	FMS	21.65	0.84	0.03	4110
2026-03-25	FMS	22.26	1.12	999.99	3213
2026-03-26	FMS	22.37	1.12	0.00	3214
2026-03-27	FMS	22.07	1.12	999.99	3217
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

15 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	FMS	23.47	22.4	587.6	2.62
2026-03-02	FMS	23.47	24.3	653.0	2.56
2026-03-03	FMS	23.37	24.3	648.9	2.56
2026-03-04	FMS	23.02	24.3	635.4	2.56
2026-03-05	FMS	23.05	24.3	667.5	2.56
2026-03-06	FMS	22.96	24.3	659.9	2.56
2026-03-09	FMS	23.43	18.9	675.1	2.56
2026-03-10	FMS	22.98	18.9	619.6	2.56
2026-03-11	FMS	22.73	18.9	609.8	2.56
2026-03-12	FMS	22.74	18.9	624.3	2.55
2026-03-13	FMS	22.78	18.9	-85.5	2.55
2026-03-17	FMS	23.15	18.9	-77.7	2.55
2026-03-18	FMS	22.40	18.9	-134.1	2.55
2026-03-19	FMS	22.12	18.9	-114.9	2.55
2026-03-20	FMS	21.65	18.9	-120.4	2.55
2026-03-23	FMS	21.89	18.9	-95.2	2.55
2026-03-24	FMS	22.03	18.9	-102.4	2.55
2026-03-25	FMS	22.28	18.9	-102.8	2.55
2026-03-26	FMS	22.36	18.9	-111.6	2.55
2026-03-27	FMS	22.07	18.9	-130.9	2.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	FMS	0.00	0.13	0.32
2026-03-02	FMS	0.00	-0.31	0.33
2026-03-03	FMS	0.00	-0.31	0.33
2026-03-04	FMS	0.00	-0.31	0.33
2026-03-05	FMS	0.00	-0.31	0.33
2026-03-06	FMS	0.00	-0.31	0.33
2026-03-09	FMS	0.00	-0.39	0.33
2026-03-10	FMS	0.00	-0.39	0.33
2026-03-11	FMS	0.00	-0.39	0.37
2026-03-12	FMS	0.00	-0.39	0.37
2026-03-13	FMS	0.00	-0.39	0.37
2026-03-17	FMS	0.00	-0.37	0.37
2026-03-18	FMS	0.00	-0.37	0.37
2026-03-19	FMS	0.00	-0.37	0.37
2026-03-20	FMS	0.00	-0.37	0.37
2026-03-23	FMS	0.00	-0.35	0.37
2026-03-24	FMS	0.00	-0.35	0.37
2026-03-25	FMS	0.00	-0.35	0.33
2026-03-26	FMS	0.00	-0.35	0.33
2026-03-27	FMS	0.00	-0.35	0.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.83

Avg. EPS Est. Current Quarter

0.5

Avg. EPS Est. Next Quarter

0.52

Insider Transactions

Institutional Transactions

-0.35

Beta

0.87

Average Sales Estimate Current Quarter

4726

Average Sales Estimate Next Quarter

4789

Fair Value

24.17

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-68.8

Target Price

25.59

P/E

11.48

Forward P/E

8.53

PEG

1.69

P/S

0.56

P/B

0.79

P/Free Cash Flow

6.16

EPS

1.92

Average EPS Est. Cur. Y

2.55

EPS Next Y. (Est.)

3.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.03

Relative Volume

0.45

Return on Equity vs Sector %

-20

Return on Equity vs Industry %

-125.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.37

EBIT Estimation

-130.9

◆ FMS Healthcare

$22.06

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

11/15

Valuation

16/20

TP/AR

0/10

Options

2/10

RSI

40.9

Range 1M

40.5%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

11/30

Estimates

4/20

Inst/Vol

0/15

Options

3/10

EPS Yr

-5.5%

EPS NY

8.7%

52W%

15%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +129.6% upside

Quality

6/30

Valuation

20/30

Growth

9/25

Stability

3/10

LT Trend

1/5

Upside

+129.6%

Quality

MoS

10%

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 109698

FMS

Latest News

—

Caricamento notizie per FMS…

stock quote shares FMS – Fresenius Medical Care AG & Co. KGaA Stock Price stock today

news today FMS – Fresenius Medical Care AG & Co. KGaA stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG & Co. KGaA yahoo finance google finance

stock history FMS – Fresenius Medical Care AG & Co. KGaA invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

SSU – SIGNA Sports United N.V.

SSU — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.16

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.02

Target Price

3.92

Analyst Recom

3.5

Performance Q

-96.71

Upside

N/A

Beta

0.55

Ticker: SSU

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-02-27	SSU	0.0937	N/A	N/A	0
2026-03-02	SSU	0.0937	N/A	N/A	0
2026-03-03	SSU	0.0937	N/A	N/A	0
2026-03-04	SSU	0.0937	N/A	N/A	0
2026-03-05	SSU	0.0937	N/A	N/A	0
2026-03-06	SSU	0.0937	N/A	N/A	0
2026-03-09	SSU	0.0937	N/A	N/A	0
2026-03-10	SSU	0.0937	N/A	N/A	0
2026-03-11	SSU	0.0937	N/A	N/A	0
2026-03-12	SSU	0.0937	N/A	N/A	0
2026-03-13	SSU	0.0937	N/A	N/A	0
2026-03-17	SSU	0.0937	N/A	N/A	0
2026-03-18	SSU	0.0937	N/A	N/A	0
2026-03-19	SSU	0.0937	N/A	N/A	0
2026-03-20	SSU	0.0937	N/A	N/A	0
2026-03-23	SSU	0.0937	N/A	N/A	0
2026-03-24	SSU	0.0937	N/A	N/A	0
2026-03-25	SSU	0.0937	N/A	N/A	0
2026-03-26	SSU	0.0937	N/A	N/A	0
2026-03-27	SSU	0.0937	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

0.55

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.8

Max Drawdown 5-Year %

Target Price

3.92

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-1.08

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-137

Return on Equity vs Industry %

-170

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for SSU

SSU

Latest News

—

Caricamento notizie per SSU…

stock quote shares SSU – SIGNA Sports United N.V. Stock Price stock today

news today SSU – SIGNA Sports United N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch SSU – SIGNA Sports United N.V. yahoo finance google finance

stock history SSU – SIGNA Sports United N.V. invest stock market

stock prices SSU premarket after hours

ticker SSU fair value insiders trading

No more stocks to show

EVO – Evotec SE

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

VJET – Voxeljet AG ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VJET

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y